No content results match your keyword.
Content
You have successfully logged out.
Not registered yet?
No product results match your keyword.
Products
Askina® Calgitrol®
Advanced Wound Care
The B. Braun Askina Calgitrol range are silver antimicrobial dressings, designed to provide sustained and conformable treatment for infected wounds in the NHS.
Infected Wounds
Wound infections can compromise the healing process, with significant negative impacts on health-relating quality of life. [1] [2]
Infected wounds cause a considerable burden to the healthcare system, bear the risk of amputation and sepsis,[3] while delaying wound healing.
It is important to find the best strategy to prevent, diagnose and manage wound infections.
-
More than
0%
of chronic wounds are estimated to be infected.[4,5]
Chronic wounds
Prevention and treatment of wound infection
The wound infection continuum looks at the different stages of wound infection, progressing from initial contamination up to sepsis,[6] [7] which can support the best strategy to prevent diagnose and manage wound infection.
Manage infected wounds covering all stages of the wound infection continuum
Choose a dressing based on
wound and patient needs
Silver dressings are available in different forms. The choice of dressing depends on the wound and patient, e.g. exudate levels, wound depth, need for conformability, odour control, ease of removal and safety.
Askina® Calgitrol® Paste
A silver alginate paste. Highly conformable, not only for small tunnels and sinuses, but suitable for all wound types like Diabetic Foot Ulcers (DFU) and Venous Leg Ulcers (VLU).
Askina® Calgitrol® Ag+
An antimicrobial silver dressing combined with reinforced fiber, for superficial highly exuding wounds.
Find out more
References
- Phillips CJ, Humphreys I, Fletcher J, Harding K, Chamberlain G, Macey S. Estimating the costs associated with the management of patients with chronic wounds using linked routine data. Int Wound J. 2016 Dec;13(6):1193-1197. doi: 10.1111/iwj.12443. Epub 2015 Mar 26. PMID: 25818405; PMCID: PMC7949824.
- Purwins S, Herberger K, Debus ES, Rustenbach SJ, Pelzer P, Rabe E, Schäfer E, Stadler R, Augustin M. Cost-of-illness of chronic leg ulcers in Germany. Int Wound J. 2010 Apr;7(2):97-102. doi: 10.1111/j.1742-481X.2010.00660.x. PMID: 20529149; PMCID: PMC7951196.
- Yammine K, El Alam A, Alqaysi B, Assi C. The internal pedal amputation as a salvage procedure in diabetic and ischemic foot infection. A meta-analysis. Foot Ankle Surg. 2022 Feb;28(2):159-165. doi: 10.1016/j.fas.2021.03.008. Epub 2021 Mar 16. PMID: 33752981
- Reitan RL, McBroom RM, Gilder RE. The Risk of Infection and Indication of Systemic Antibiotics in Chronic Wounds. Wounds. 2020 Jul;32(7):186-194. PMID: 33166266.
- Schollemann F, Kunczik J, Dohmeier H, Pereira CB, Follmann A, Czaplik M. Infection Probability Index: Implementation of an Automated Chronic Wound Infection Marker. J Clin Med. 2021 Dec 29;11(1):169. doi: 10.3390/jcm11010169. PMID: 35011910; PMCID: PMC8745914
- Kingsley A. The wound infection continuum and its application to clinical practice. Ostomy Wound Manage. 2003 Jul;49(7A Suppl):1-7. PMID: 12883156.
- Deeth M. A closer look at the wound infection continuum. Br J Community Nurs. 2017 Dec 1;22(Sup12):S48-S50. doi: 10.12968/bjcn.2017.22.Sup12.S48. PMID: 29189070.